Want to join the conversation?
$ZTS said that operationally, revenue grew 4% in 1Q16. The results reflect six extra days due to the accounting calendar, as well as the negative impact of changes in markets like Venezuela and India, and product rationalization. Adjusting for these factors, the company's growth will be 10% operational and 6% excluding the impact of acquisitions.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.